| NEMRX | VEMIX | NEMRX / VEMIX | |
| Total Expense Ratio | 1.95 | 0.09 | 2,167% |
| Annual Report Gross Expense Ratio | 2.25 | 0.09 | 2,500% |
| Fund Existence | 15 years | 25 years | - |
| Gain YTD | 30.524 | 22.333 | 137% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 222M | 141B | 0% |
| Annual Yield % from dividends | 0.00 | 2.78 | - |
| Returns for 1 year | 29.39 | 20.34 | 145% |
| Returns for 3 years | 52.40 | 47.78 | 110% |
| Returns for 5 years | 17.27 | 24.17 | 71% |
| Returns for 10 years | 75.48 | 80.60 | 94% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MGTIX | 46.97 | N/A | N/A |
| MFS Massachusetts Inv Gr Stk I | |||
| KCGSX | 24.17 | N/A | N/A |
| Knights of Columbus Large Cap Growth S | |||
| MSFBX | 31.89 | N/A | N/A |
| Morgan Stanley Inst Global Franchise A | |||
| NBRRX | 27.27 | N/A | N/A |
| Neuberger Berman M/C Intrinsic Val R3 | |||
| IVOAX | 18.85 | -0.05 | -0.26% |
| Macquarie Mid Cap Income Opps A | |||